Annual Report

Overview

The report describes a FY24 revenue of ₹2,087.02 million and the acquisition of Yash Pharma's India and Bhutan business, expanding Jagsonpal's dermatology and paediatric portfolio. It highlights the MySakhi women's-health platform, virtual awareness sessions, and construction of four toilet complexes in Uttarakhand and Punjab. The report also emphasizes employee development through STEP, VLEAD, and PROGM training initiatives.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023-2024
Period: 1 April 2023 – 31 March 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services